Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis

Juan Xiao, Rongbing Yang, Sangita Biswas, Yunhua Zhu, Xin Qin, Min Zhang, Lihong Zhai, Yi Luo, Xiaoming He, Chun Mao, Wenbin Deng

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory, and demyelinating disorder of the central nervous system (CNS), which ultimately leads to axonal loss and permanent neurological disability. Current treatments for MS are largely comprised of medications that are either immunomodulatory or immunosuppressive and are aimed at reducing the frequency and intensity of relapses. Neural stem cells (NSCs) in the adult brain can differentiate into oligodendrocytes in a context-specific manner and are shown to be involved in the remyelination in these patients. NSCs may exert their beneficial effects not only through oligodendrocyte replacement but also by providing trophic support and immunomodulation, a phenomenon now known as “therapeutic plasticity.” In this review, we first provided an update on the current knowledge regarding MS pathogenesis and the role of immune cells, microglia, and oligodendrocytes in MS disease progression. Next, we reviewed the current progress on research aimed toward stimulating endogenous NSC proliferation and differentiation to oligodendrocytes in vivo and in animal models of demyelination. In addition, we explored the neuroprotective and immunomodulatory effects of transplanted exogenous NSCs on T cell activation, microglial activation, and endogenous remyelination and their effects on the pathological process and prognosis in animal models of MS. Finally, we examined various protocols to generate genetically engineered NSCs as a potential therapy for MS. Overall, this review highlights the studies involving the immunomodulatory, neurotrophic, and regenerative effects of NSCs and novel methods aiming at stimulating the potential of NSCs for the treatment of MS.

Original languageEnglish (US)
Pages (from-to)1-20
Number of pages20
JournalMolecular Neurobiology
DOIs
StateAccepted/In press - May 2 2017

Fingerprint

Neural Stem Cells
Multiple Sclerosis
Oligodendroglia
Demyelinating Diseases
Therapeutics
Animal Models
Immunomodulation
Microglia
Neuroprotective Agents
Pathologic Processes
Immunosuppressive Agents
Disease Progression
Cell Differentiation
Central Nervous System
Cell Proliferation
T-Lymphocytes
Recurrence
Brain
Research

Keywords

  • Microglia
  • Multiple sclerosis
  • Neural progenitor cell
  • Neural stem cell
  • Oligodendrocyte

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis. / Xiao, Juan; Yang, Rongbing; Biswas, Sangita; Zhu, Yunhua; Qin, Xin; Zhang, Min; Zhai, Lihong; Luo, Yi; He, Xiaoming; Mao, Chun; Deng, Wenbin.

In: Molecular Neurobiology, 02.05.2017, p. 1-20.

Research output: Contribution to journalArticle

Xiao, J, Yang, R, Biswas, S, Zhu, Y, Qin, X, Zhang, M, Zhai, L, Luo, Y, He, X, Mao, C & Deng, W 2017, 'Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis', Molecular Neurobiology, pp. 1-20. https://doi.org/10.1007/s12035-017-0566-7
Xiao, Juan ; Yang, Rongbing ; Biswas, Sangita ; Zhu, Yunhua ; Qin, Xin ; Zhang, Min ; Zhai, Lihong ; Luo, Yi ; He, Xiaoming ; Mao, Chun ; Deng, Wenbin. / Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis. In: Molecular Neurobiology. 2017 ; pp. 1-20.
@article{425c7b0b94fb4357ade0f3b1a3eeb634,
title = "Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis",
abstract = "Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory, and demyelinating disorder of the central nervous system (CNS), which ultimately leads to axonal loss and permanent neurological disability. Current treatments for MS are largely comprised of medications that are either immunomodulatory or immunosuppressive and are aimed at reducing the frequency and intensity of relapses. Neural stem cells (NSCs) in the adult brain can differentiate into oligodendrocytes in a context-specific manner and are shown to be involved in the remyelination in these patients. NSCs may exert their beneficial effects not only through oligodendrocyte replacement but also by providing trophic support and immunomodulation, a phenomenon now known as “therapeutic plasticity.” In this review, we first provided an update on the current knowledge regarding MS pathogenesis and the role of immune cells, microglia, and oligodendrocytes in MS disease progression. Next, we reviewed the current progress on research aimed toward stimulating endogenous NSC proliferation and differentiation to oligodendrocytes in vivo and in animal models of demyelination. In addition, we explored the neuroprotective and immunomodulatory effects of transplanted exogenous NSCs on T cell activation, microglial activation, and endogenous remyelination and their effects on the pathological process and prognosis in animal models of MS. Finally, we examined various protocols to generate genetically engineered NSCs as a potential therapy for MS. Overall, this review highlights the studies involving the immunomodulatory, neurotrophic, and regenerative effects of NSCs and novel methods aiming at stimulating the potential of NSCs for the treatment of MS.",
keywords = "Microglia, Multiple sclerosis, Neural progenitor cell, Neural stem cell, Oligodendrocyte",
author = "Juan Xiao and Rongbing Yang and Sangita Biswas and Yunhua Zhu and Xin Qin and Min Zhang and Lihong Zhai and Yi Luo and Xiaoming He and Chun Mao and Wenbin Deng",
year = "2017",
month = "5",
day = "2",
doi = "10.1007/s12035-017-0566-7",
language = "English (US)",
pages = "1--20",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",

}

TY - JOUR

T1 - Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis

AU - Xiao, Juan

AU - Yang, Rongbing

AU - Biswas, Sangita

AU - Zhu, Yunhua

AU - Qin, Xin

AU - Zhang, Min

AU - Zhai, Lihong

AU - Luo, Yi

AU - He, Xiaoming

AU - Mao, Chun

AU - Deng, Wenbin

PY - 2017/5/2

Y1 - 2017/5/2

N2 - Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory, and demyelinating disorder of the central nervous system (CNS), which ultimately leads to axonal loss and permanent neurological disability. Current treatments for MS are largely comprised of medications that are either immunomodulatory or immunosuppressive and are aimed at reducing the frequency and intensity of relapses. Neural stem cells (NSCs) in the adult brain can differentiate into oligodendrocytes in a context-specific manner and are shown to be involved in the remyelination in these patients. NSCs may exert their beneficial effects not only through oligodendrocyte replacement but also by providing trophic support and immunomodulation, a phenomenon now known as “therapeutic plasticity.” In this review, we first provided an update on the current knowledge regarding MS pathogenesis and the role of immune cells, microglia, and oligodendrocytes in MS disease progression. Next, we reviewed the current progress on research aimed toward stimulating endogenous NSC proliferation and differentiation to oligodendrocytes in vivo and in animal models of demyelination. In addition, we explored the neuroprotective and immunomodulatory effects of transplanted exogenous NSCs on T cell activation, microglial activation, and endogenous remyelination and their effects on the pathological process and prognosis in animal models of MS. Finally, we examined various protocols to generate genetically engineered NSCs as a potential therapy for MS. Overall, this review highlights the studies involving the immunomodulatory, neurotrophic, and regenerative effects of NSCs and novel methods aiming at stimulating the potential of NSCs for the treatment of MS.

AB - Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory, and demyelinating disorder of the central nervous system (CNS), which ultimately leads to axonal loss and permanent neurological disability. Current treatments for MS are largely comprised of medications that are either immunomodulatory or immunosuppressive and are aimed at reducing the frequency and intensity of relapses. Neural stem cells (NSCs) in the adult brain can differentiate into oligodendrocytes in a context-specific manner and are shown to be involved in the remyelination in these patients. NSCs may exert their beneficial effects not only through oligodendrocyte replacement but also by providing trophic support and immunomodulation, a phenomenon now known as “therapeutic plasticity.” In this review, we first provided an update on the current knowledge regarding MS pathogenesis and the role of immune cells, microglia, and oligodendrocytes in MS disease progression. Next, we reviewed the current progress on research aimed toward stimulating endogenous NSC proliferation and differentiation to oligodendrocytes in vivo and in animal models of demyelination. In addition, we explored the neuroprotective and immunomodulatory effects of transplanted exogenous NSCs on T cell activation, microglial activation, and endogenous remyelination and their effects on the pathological process and prognosis in animal models of MS. Finally, we examined various protocols to generate genetically engineered NSCs as a potential therapy for MS. Overall, this review highlights the studies involving the immunomodulatory, neurotrophic, and regenerative effects of NSCs and novel methods aiming at stimulating the potential of NSCs for the treatment of MS.

KW - Microglia

KW - Multiple sclerosis

KW - Neural progenitor cell

KW - Neural stem cell

KW - Oligodendrocyte

UR - http://www.scopus.com/inward/record.url?scp=85018446604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018446604&partnerID=8YFLogxK

U2 - 10.1007/s12035-017-0566-7

DO - 10.1007/s12035-017-0566-7

M3 - Article

C2 - 28466274

AN - SCOPUS:85018446604

SP - 1

EP - 20

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -